Chimerix reported $11.65M in Operating Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Ardelyx ARDX:US USD -21880000 4.34M
Chimerix CMRX:US USD 11.65M 35.09M
Curis CRIS:US USD -12606000 2.46M
Dynavax Technologies DVAX:US USD 61.4M 66.83M
Emergent Biosolutions EBS:US USD -42000000 30M
Gilead Sciences GILD:US USD 2.27B 570M
Glaxosmithkline GSK:US GBP 1.87B 677M
Life Technologies LIFE:US USD -13492000 908K
Merk MRK:US USD 3.51B 505M
Mirati Therapeutics MRTX:US USD -186443000 9.24M
Novavax NVAX:US USD -127189000 355.77M
Xoma XOMA:US USD -4372000 395K